← back to search

Lan Luo

North Carolina State University · US
Area of research
Radiology, Nuclear Medicine and Imaging · Genetics
Research interest
Research interests include Medicine, Autophagy, Stem cell, Mitophagy, Cancer stem cell, and Chemistry.
h-index
citations
515
works
15
NIH funding
primary concept
email

Recent publications

iPLA2β/p38 MAPK alleviates the blood brain barrier disruption and brain injury in rats after TBI by inhibiting autophagy and tight junction damage: In vitro and in vivo studies
Experimental Neurology 2025cited by 4position: middledoi
Momordica charantia L.-derived exosome-like nanovesicles stabilize p62 expression to ameliorate doxorubicin cardiotoxicity
Journal of Nanobiotechnology 2024cited by 51position: lastdoi
Nicotinamide N-oxide Inhibits Microglial Pyroptosis by Upregulating Mitophagy and Alleviates Neural Damage in Rats after TBI
Inflammation 2024cited by 2position: middledoi
New Insights into the Understanding of Mechanisms of Radiation-Induced Heart Disease
Current Treatment Options in Oncology 2023cited by 38position: lastdoi
Increased endogenous PKG I activity attenuates EGF-induced proliferation and migration of epithelial ovarian cancer via the MAPK/ERK pathway
Cell Death and Disease 2023cited by 23position: lastdoi
POEMS syndrome: origination from clonal plasma cells or B cells?
Hematology 2023cited by 3position: middledoi
Momordica. charantia-Derived Extracellular Vesicles-Like Nanovesicles Protect Cardiomyocytes Against Radiation Injury via Attenuating DNA Damage and Mitochondria Dysfunction
Frontiers in Cardiovascular Medicine 2022cited by 80position: lastdoi
Cinnamaldehyde Suppressed EGF-Induced EMT Process and Inhibits Ovarian Cancer Progression Through PI3K/AKT Pathway
Frontiers in Pharmacology 2022cited by 36position: middledoi
Enhanced autophagy promotes radiosensitivity by mediating Sirt1 downregulation in RM-1 prostate cancer cells
Biochemical and Biophysical Research Communications 2022cited by 10position: lastdoi
Construction and validation of a m6A RNA methylation and ferroptosis-related prognostic model for pancreatic cancer by integrated bioinformatics analysis
Journal of Gastrointestinal Oncology 2022cited by 10position: middledoi
Mesenchymal Stem Cells for Mitigating Radiotherapy Side Effects
Cells 2021cited by 38position: lastdoi
Enhanced expression of PKM2 associates with the biological properties of cancer stem cells from A549 human lung cancer cells
Oncology Reports 2017cited by 16position: middledoi
Doxorubicin-induced mitophagy contributes to drug resistance in cancer stem cells from HCT8 human colorectal cancer cells
Cancer Letters 2016cited by 165position: middledoi
Sequential Differentiation of Embryonic Stem Cells into Neural Epithelial-Like Stem Cells and Oligodendrocyte Progenitor Cells
PLoS ONE 2016cited by 15position: middledoi
Effects of antioxidants on the quality and genomic stability of induced pluripotent stem cells
Scientific Reports 2014cited by 24position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Tao‐Sheng Li · North Carolina State University5 papers (2014–2024)Ting Lan · Jiangsu University5 papers (2021–2023)Ping Ma · Nanchang University3 papers (2022–2023)Bing Gu · Guangdong Academy of Medical Sciences3 papers (2022–2023)Yan Chen · Nanchang University3 papers (2016–2022)Yan Chen · Nanchang University3 papers (2022–2024)Shinji Goto · Johns Hopkins Medicine3 papers (2014–2017)Kaixuan Wang · Dalian Medical University3 papers (2021–2023) · 3 papers (2014–2017)Suhua Qi · Hebei Medical University3 papers (2022–2024)Yang Xu · University of South China3 papers (2021–2023)Aibin Tao · Jiangsu University3 papers (2021–2023)Cong Ye · Ningbo University2 papers (2022–2024)Cong Ye · Ningbo University2 papers (2022–2023)Xiaoyan Li · Guangzhou University of Chinese Medicine2 papers (2024–2025)Wan Wang · Fudan University2 papers (2022–2022)Xiangcheng Zhao · Harbin Medical University2 papers (2024–2025)Linyan Huang · Guangdong University of Technology2 papers (2022–2022)Kaixuan Wang · Xuzhou Medical College2 papers (2022–2024)Wenwen Cui · Shenyang Pharmaceutical University2 papers (2022–2022)